Annual Accounts Payable
$2.50 M
+$403.00 K+19.24%
December 31, 2023
Summary
- As of February 7, 2025, MBRX annual accounts payable is $2.50 million, with the most recent change of +$403.00 thousand (+19.24%) on December 31, 2023.
- During the last 3 years, MBRX annual accounts payable has risen by +$1.37 million (+121.26%).
- MBRX annual accounts payable is now at all-time high.
Performance
MBRX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.55 M
-$283.00 K-9.99%
September 30, 2024
Summary
- As of February 7, 2025, MBRX quarterly accounts payable is $2.55 million, with the most recent change of -$283.00 thousand (-9.99%) on September 30, 2024.
- Over the past year, MBRX quarterly accounts payable has increased by +$446.00 thousand (+21.20%).
- MBRX quarterly accounts payable is now -38.35% below its all-time high of $4.14 million, reached on June 30, 2023.
Performance
MBRX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MBRX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.2% | +21.2% |
| 3 y3 years | +121.3% | -38.4% |
| 5 y5 years | +100.5% | -38.4% |
MBRX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.1% | -38.4% | +87.0% |
| 5 y | 5-year | at high | +121.3% | -38.4% | +125.9% |
| alltime | all time | at high | +526.1% | -38.4% | +539.1% |
Moleculin Biotech Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.55 M(-10.0%) |
| Jun 2024 | - | $2.83 M(+34.6%) |
| Mar 2024 | - | $2.10 M(-15.8%) |
| Dec 2023 | $2.50 M(+19.2%) | $2.50 M(+24.4%) |
| Sep 2023 | - | $2.01 M(-51.5%) |
| Jun 2023 | - | $4.14 M(+113.3%) |
| Mar 2023 | - | $1.94 M(-7.4%) |
| Dec 2022 | $2.10 M(+53.6%) | $2.10 M(-41.3%) |
| Sep 2022 | - | $3.57 M(+12.1%) |
| Jun 2022 | - | $3.18 M(+43.2%) |
| Mar 2022 | - | $2.22 M(+63.0%) |
| Dec 2021 | $1.36 M(+20.8%) | $1.36 M(-1.9%) |
| Sep 2021 | - | $1.39 M(-7.6%) |
| Jun 2021 | - | $1.50 M(-21.9%) |
| Mar 2021 | - | $1.93 M(+70.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $1.13 M(-47.6%) | $1.13 M(-15.9%) |
| Sep 2020 | - | $1.34 M(-30.0%) |
| Jun 2020 | - | $1.92 M(+59.0%) |
| Mar 2020 | - | $1.21 M(-44.0%) |
| Dec 2019 | $2.15 M(+72.8%) | $2.15 M(-32.5%) |
| Sep 2019 | - | $3.19 M(+153.6%) |
| Jun 2019 | - | $1.26 M(-55.1%) |
| Mar 2019 | - | $2.80 M(+124.6%) |
| Dec 2018 | $1.25 M(+53.8%) | $1.25 M(+58.7%) |
| Sep 2018 | - | $785.00 K(-53.2%) |
| Jun 2018 | - | $1.68 M(+194.0%) |
| Mar 2018 | - | $570.00 K(-29.6%) |
| Dec 2017 | $810.00 K(+103.0%) | $810.00 K(+103.0%) |
| Dec 2016 | $399.00 K | $399.00 K(-57.8%) |
| Sep 2016 | - | $945.00 K(+31.0%) |
| Jun 2016 | - | $721.10 K |
FAQ
- What is Moleculin Biotech annual accounts payable?
- What is the all time high annual accounts payable for Moleculin Biotech?
- What is Moleculin Biotech annual accounts payable year-on-year change?
- What is Moleculin Biotech quarterly accounts payable?
- What is the all time high quarterly accounts payable for Moleculin Biotech?
- What is Moleculin Biotech quarterly accounts payable year-on-year change?
What is Moleculin Biotech annual accounts payable?
The current annual accounts payable of MBRX is $2.50 M
What is the all time high annual accounts payable for Moleculin Biotech?
Moleculin Biotech all-time high annual accounts payable is $2.50 M
What is Moleculin Biotech annual accounts payable year-on-year change?
Over the past year, MBRX annual accounts payable has changed by +$403.00 K (+19.24%)
What is Moleculin Biotech quarterly accounts payable?
The current quarterly accounts payable of MBRX is $2.55 M
What is the all time high quarterly accounts payable for Moleculin Biotech?
Moleculin Biotech all-time high quarterly accounts payable is $4.14 M
What is Moleculin Biotech quarterly accounts payable year-on-year change?
Over the past year, MBRX quarterly accounts payable has changed by +$446.00 K (+21.20%)